Pressure BioSciences's EBIT per Share for the
three
months ended in Sep. 2023 was $-0.06.
Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.34.
During the past 3 years, the average EBIT per Share Growth Rate was 46.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 37.70% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 25.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Pressure BioSciences's EBIT per Share or its related term are showing as below:
PBIO'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -92.3 Med: 18.7 Max: 46.7
Current: 46.7
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Pressure BioSciences was 46.70% per year. The lowest was -92.30% per year. And the median was 18.70% per year.
PBIO's 3-Year EBIT Growth Rate is ranked better than 89.57% of 729
companies
in the Medical Devices & Instruments industry
Industry Median: 5.8
vs PBIO: 46.70
Pressure BioSciences EBIT per Share Historical Data
The historical data trend for Pressure BioSciences's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.34
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pressure BioSciences (OTCPK:PBIO) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Pressure BioSciences EBIT per Share Related Terms
Thank you for viewing the detailed overview of Pressure BioSciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Pressure BioSciences (Pressure BioSciences) Business Description
Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of innovative, enabling, pressure-based platform solutions for the worldwide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PBIO has been successfully added to your 